long half-life and large variability [Regulatives / Guidelines]

posted by Achievwin – US, 2020-08-12 17:22 (910 d 17:44 ago) – Posting: # 21864
Views: 1,493

Welcome to the home of funky and funny pharmacokinetics where "Garbage in Gospel out" is day of life.

1. allowing long washout periods have seen studies with 4 -5 months washout.
2. other choice we can imagine is Two stage adaptive study design and including ANCOA in place of ANOVA...

want to know what other experts think?

❝ In short:

Complete thread:

UA Flag
 Admin contact
22,488 posts in 4,711 threads, 1,605 registered users;
26 visitors (1 registered, 25 guests [including 3 identified bots]).
Forum time: 10:07 CET (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz